Invention Application
- Patent Title: USE OF LANOSTANE AND PORIA EXTRACT IN TREATING DIABETES
- Patent Title (中): 使用兰斯坦和波利亚提取物治疗糖尿病
-
Application No.: US12854037Application Date: 2010-08-10
-
Publication No.: US20110053899A1Publication Date: 2011-03-03
- Inventor: Hang-Ching Lin , Yu-Chuan Huang , Tsu-Chung Chang , Wen-Liang Chang
- Applicant: Hang-Ching Lin , Yu-Chuan Huang , Tsu-Chung Chang , Wen-Liang Chang
- Applicant Address: CN Hangzhou
- Assignee: SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD (HANGZHOU)
- Current Assignee: SINPHAR TIAN-LI PHARMACEUTICAL CO., LTD (HANGZHOU)
- Current Assignee Address: CN Hangzhou
- Priority: CN200910168119.9 20090828
- Main IPC: A61K31/575
- IPC: A61K31/575 ; A61P3/10
Abstract:
A pharmaceutical composition for treating diabetes is provided in this invention. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is a Poria extract from metabolite, sclerotium, or fermentation product of Poria cocos (Schw) Wolf. The Poria extract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.
Public/Granted literature
- US09084798B2 Use of lanostane and Poria extract in treating diabetes Public/Granted day:2015-07-21
Information query
